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Naturally occurring hydroxamic acid derivatives are biosynthesized by
microorganisms (siderophores) and plants (benzoxazinoids). Recent developments
in drug discovery have highlighted the numerous biological and pharmacological
properties that the hydroxamic acid function may possess, leading to therapeutic
applications. These properties may be explained by its ability to chelate metals via
the presence of two oxygen atoms. Their pharmacological activities can be divided
into three groups. The first concerns the ability of these hydroxamic acid derivatives
to scavenge metals (particularly iron), which leads to antioxidant, antimicrobial and
metal detoxification activities. The latter is largely used to treat iron overload in
patients. The second group of activities is related to their ability to inhibit metallo-
enzymes, which gives them a wide range of pharmacological effects: antimicrobial,
anti-inflammatory and antitumor. The third group is linked to the capacity of these
compounds to generate nitric oxide, which confers hypotensive activity. However,
hydroxamates exhibit relatively low stability in vivo, which can be overcome by the
synthesis of appropriately designed analogs. For this purpose, many different
strategies have been proposed. In this review, we compare and discuss the various
synthetic pathways used to obtain the most complex of them, the N-substituted
hydroxamic acids. We conclude that among numerous protocols reported so far, the
direct N-substitution of hydroxamic acids, the acylation of the appropriate N-O
derivative and the direct oxidation of the corresponding amide allow for the
synthesis of a wide range of new biologically active compounds.
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